John Noseworthy joins AlixPartners board of directors

09 April 2019 2 min. read
More news on

Consulting firm AlixPartners has added John Noseworthy, M.D., the former president and CEO of Mayo Clinic, as a member of its board of directors.

Noseworthy retired from his position as president and CEO of Mayo Clinic at the end of 2018, having spent nearly 10 years helming one of the US’ most prestigious nonprofit academic health systems. The leading health organization operates in five states, and annually treats more than 1 million people nationwide and from and nearly 150 countries. In 2018, it was named the Best Hospital in U.S. News & World Report’s annual rankings, for the third consecutive year.

Before his time as CEO, Noseworthy was chair of Mayo Clinic’s department of neurology and medical director of the department of development. He was also a professor of neurology at the Mayo Clinic College of Medicine, specializing in multiple sclerosis. He spent more than 20 years designing and conducting clinical trials, and authored more than 150 research papers, chapters, editorials, and several books.

Noseworthy holds a Doctor of Medicine from Dalhousie University in Halifax, Canada.

John Noseworthy - AlixPartners“I am delighted to welcome John to the AlixPartners board,” Simon Freakley, AlixPartners CEO, said. “At the time he was appointed CEO, the Mayo Clinic, along with many other health care organizations, was suffering the effects of a nationwide recession. John’s leadership and innovation played a key part in transforming Mayo’s profitability, as well as driving consistent high performance in health care quality, safety, and research, and championing the latest technology.

“John’s unique experience brings a valuable perspective to our board as we continue to grow AlixPartners,” Freakley added.

Noseworthy currently sits on the board of directors for UnitedHealth Group, the largest healthcare company in the world by revenue ($226.2 billion in 2018). He is also a board member at pharmaceutical giant Merck & Co.

The high-profile addition of Dr. Noseworthy follows the November appointment of Jill Smart to AlixPartners’ board of directors. Smart was formerly the chief human resources officer at Accenture, overseeing the near tripling of the consultancy’s workforce from 100,000 to 281,000.